Solana Co — Director's Dealing 2021

Jun 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-06-02

Reporting Person: ANDREEFF DANE (Director, Interim President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-02	Stock Option (Right to Buy)	$13.35	A	90000	Acquired	2031-06-01	Common Stock (90000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The option was fully vested on the grant date.